Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSB2400008	RO7030816	mosunetuzumab	Injection	Biological Products	Supplementary Application	2024-01-30					view
JXSB2400007	RO7030816	mosunetuzumab	Injection	Biological Products	Supplementary Application	2024-01-30					view
JXSL2300019	RO7030816	mosunetuzumab	Injection	Biological Products(2.1)	Import Drug Application	2023-01-07					view
JXSL2300018	RO7030816	mosunetuzumab	Injection	Biological Products(2.1)	Import Drug Application	2023-01-07					view
JXSB2101093	RO7030816	mosunetuzumab	Injection	Biological Products(1)	Supplementary Application	2021-11-25					view
JXSB2101094	RO7030816	mosunetuzumab	Injection	Biological Products(1)	Supplementary Application	2021-11-25					view
JXSL2101073	RO7030816	mosunetuzumab	Injection	Biological Products(1)	Import Drug Application	2021-07-26					view
JXSL2101072	RO7030816	mosunetuzumab	Injection	Biological Products(1)	Import Drug Application	2021-07-26					view
JXSL2101057	RO7030816	mosunetuzumab	Injection	Biological Products(1)	Import Drug Application	2021-06-30					view
JXSL2101058	RO7030816	mosunetuzumab	Injection	Biological Products(1)	Import Drug Application	2021-06-30					view
JXSL2100016	RO7030816	mosunetuzumab	Injection	Biological Products(1)	Import Drug Application	2021-02-03	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2021-02-02	view
JXSL2100015	RO7030816	mosunetuzumab	Injection	Biological Products(1)	Import Drug Application	2021-02-03	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2021-02-02	view